Jiang Du
Green Catalysis Center
Zhengzhou, 450001, China
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
PCSK9 alleviates doxorubicin‑induced pyroptosis of cardiomyocytes.
Journal: Molecular medicine reports
Published: January 17, 2026
PARP1 stabilizes FOXN3 to suppress pulmonary fibrosis through p38-related feedback regulation.
Journal: Science advances
Published: January 02, 2026
Immuno-modulatory nanozyme film with self-switchable activity for adaptive infection-inflammation-repair cascade in wound infection therapy and healing.
Journal: Materials today. Bio
Published: October 21, 2025
METTL1-deficient mesenchymal stem cells protect against metabolic-associated fatty liver disease by increasing NAMPT secretion.
Journal: Stem cells translational medicine
Published: September 24, 2025
RNF186 controls glucose metabolism in metabolic dysfunction-associated fatty liver disease.
Journal: Cell & bioscience
Published: July 08, 2025
METTL1-mediated m7G methylation of FoxO1 regulates lipid metabolism in metabolic dysfunction-associated fatty liver disease.
Journal: Metabolism: clinical and experimental
Published: June 05, 2025
GBsim: A Robust GCN-BERT Approach for Cross-Architecture Binary Code Similarity Analysis.
Journal: Entropy (Basel, Switzerland)
Published: March 10, 2025
MSC-EV-transmitted HSPA8 alleviates cisplatin-induced ovotoxicity by regulating the MGARP/PRDX2 axis.
Journal: International journal of biological macromolecules
Published: July 23, 2024
Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease.
Journal: World journal of stem cells
Published: March 13, 2024
Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.
Journal: Metabolism: clinical and experimental
Published: August 29, 2023
Last Updated: 09/26/2026